Science
Navigating diagnostics: Will testing leave the lab and move to the community
On the back of a new report on the future of diagnostics, we look at whether lab services are likely to be moved out into the community.
Proud of our progress
David Wells, IBMS Chief Executive, takes a look at where the Institute is and where it’s heading.
News
-
Artificial enzymes programmed to destroy SARS-CoV-2
Cambridge scientists have used synthetic biology to create artificial enzymes programmed to target the genetic code of SARS-CoV-2 and destroy the virus.
Molecular Pathology & Genomics -
Genes identified to potentially diagnose Lyme disease
Researchers at the Icahn School of Medicine at Mount Sinai in New York have identified 35 genes that are particularly highly expressed in people with long-term Lyme disease.
Haematology & Transfusion Science -
How stealthy HIV evades drugs and immunity
An immune response that likely evolved to help fight infections appears to be the mechanism that drives human immunodeficiency virus (HIV) into a latent state, researchers at Duke Health in the US report.
Microbiology & Virology
Science
IBMS research grants 2022
The four recipients of IBMS research grants in 2022 explain their projects and the impact they hope their work will have.
The big question: The biomedical science workforce
This month we ask “How can we solve the workforce shortage in biomedical science?”
Pushing back the frontiers with "click chemistry"
Ben Schumann discusses his work and the potential to understand the complex molecular and cellular processes at work in diseases.
Latest Jobs
IBMS Twitter
Resources
My lab: a hub-and-spoke network
Consultant Clinical Biochemist Dr Allison Chipchase gives a guided tour of the Eastern Pathology Alliance laboratories.
